Therapeutic effects of a soluble guanylate cyclase activator, BAY 60-2770, on lower urinary tract dysfunction in mice with spinal cord injury
* Corresponding Author; email: [email protected]
1Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
3Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
留言 (0)